Investors pump another $8.8M into KC medical device startup, bringing funding total to $20M+
March 31, 2020 | Startland News Staff
A Fairway-based medical device company is getting to the heart of its entrepreneurial journey, securing a fresh $8.8 million in Series A financing, Dr. Nicholas Franano announced Tuesday.
The additional influx to Artio — rebranded from “Metactive” earlier this winter — brings the startup’s total capital raised to more than $20 million. The company has spent years developing groundbreaking, best-in-class products for the peripheral vascular and neurovascular markets, said Franano, founder, president and CEO of Artio.
“We appreciate the strong support from our new and existing investors,” he said. “Our team is looking forward to making our innovative products available to physicians and patients.”
Click here to see why Artio/Metactive was named one of Startland News’ Kansas City Startups to Watch in 2019.
Funds from the latest round are expected to help Artio obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market its Solus Gold Embolization Device in the United States.
Solus Gold Embolization Device
The Solus Gold is the first metal implant to provide a solid barrier to blood flow, and is developed for peripheral vascular embolization — a minimally invasive procedure that blocks or reduces blood flow in blood vessels for patients experiencing life-threatening bleeding and other serious medical conditions.
The combination of a low-profile, flexible delivery system and a detachable gold metal implant is designed for passage through tortuous blood vessels, precision placement, and immediate vessel occlusion after placement of a single device, according to the company.
Franano’s team also has revealed two other next-gen embolization products, the Solus Flex device and Aneura system.
Click here to learn more about these peripheral vascular solutions.
“Artio is developing a strong portfolio of disruptive, next-generation peripheral vascular and neurovascular embolization products, and we were thrilled to help lead the latest round of funding,” said Nathaniel Hagedorn, founder and CEO of Northpoint Development. “I have been incredibly fortunate to have so many people help me build my business and am happy to ‘pay it forward’ to a fellow entrepreneur with a clear vision and accomplished team.”
Featured Business
2020 Startups to Watch
stats here
Related Posts on Startland News
Techweek commits to five more years in KC
With more than 5,000 attendees last week in Union Station, Kansas City more than doubled the expected participation in Techweek, a week-long technology conference. In fact, Kansas City performed so well that Techweek is coming back for at least five more years. Techweek CEO Katy Lynch said that the conference was anticipating about 2,500 attendees, but…
Science City at Union Station wins experience award
Science City at Union Station was named one of two worldwide recipients for a prestigious visitor experience award. The EDGIE Award, or Roy L. Shafer Leading Edge Award, for visitor experience was given to Science City last week by the Association of Science-Technology Centers, a nonprofit organization that represents science centers and museums. The award…
OP prescription software firm lands $2.7M
An Overland Park software company recently wrapped up a hefty funding round, according to its founder and CEO. Rx Savings Solutions, a business that works with other companies to manage employees’ monthly medications, secured $2.7 million in funding. Kansas City investors Dan Henry, CEO of NetSpend Corp., and Jeffrey Brown, chairman at StoreFinancial, led the…
LaunchKC winners reflect on ‘massive opportunity’
Once the dust settled on the LaunchKC grant recipient announcement, the champagne bottles popped. Founders from the 10 winning companies — parred down from a list of 500 — had reason to celebrate Friday afternoon between the promise of $50,000 and the chance to land some office space. Of the 10 recipient companies, six come…